Understanding inflammation in chronic obstructive pulmonary disease: The process begins

American Journal of Respiratory and Critical Care Medicine

Volumn 167, Issue 8, 2003, Pages 1045-1046

  Snider, Gordon L ^a  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA 1 ANTITRYPSIN; DESMOSINE; HYDROXYPROLINE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LEUKOCYTE ELASTASE; MACROPHAGE ELASTASE; MACROPHAGE INFLAMMATORY PROTEIN; MACROPHAGE INFLAMMATORY PROTEIN 2; METALLOPROTEINASE; METALLOPROTEINASE INHIBITOR; TOBACCO SMOKE; TOXIC GAS; TOXIC SUBSTANCE; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR ALPHA RECEPTOR;

AIRWAY OBSTRUCTION; ALPHA 1 ANTITRYPSIN DEFICIENCY; AMINO ACID ANALYSIS; ANAMNESIS; BIOLOGICAL MODEL; CELL ASSAY; CELL COUNT; CHRONIC OBSTRUCTIVE LUNG DISEASE; CIGARETTE SMOKING; COHORT ANALYSIS; COMPUTER ASSISTED TOMOGRAPHY; DISEASE SEVERITY; DRUG RESEARCH; EDITORIAL; ELASTIC FIBER; EMPHYSEMA; ENZYME ANALYSIS; ENZYME SYNTHESIS; EOSINOPHIL; GENE EXPRESSION; IN VITRO STUDY; IN VIVO STUDY; INFLAMMATION; INTRACELLULAR TRANSPORT; KNOCKOUT MOUSE; LABORATORY; LUNG ALVEOLUS MACROPHAGE; LYMPHOCYTE; NEUTROPHIL; NONHUMAN; PATHOGENESIS; PNEUMONIA; PRIORITY JOURNAL; SMOKING; SMOKING CESSATION; WILD TYPE;

ANIMALS; HUMANS; INFLAMMATION; MATRIX METALLOPROTEINASE 12; METALLOENDOPEPTIDASES; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; SMOKING;

EID: 0037447192     PISSN: 1073449X     EISSN: None     Source Type: Journal    
DOI: 10.1164/rccm.2302002     Document Type: Editorial

References (16)

1. Snider GL. Nosology for our day: its application to chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2003;167:678-683.
2. Saetta M, Turato G, Luppi F, Fabbri LM. Inflammation in the pathogenesis of chronic obstructive pulmonary disease. In: Voelkel NF, MacNee W, editors. Chronic obstructive pulmonary disease. Hamilton, ON, Canada: BC Decker; 2002. p. 114-126.
3. 1-antitrypsin deficiency. Acta Med Scand 1964;175:197-205.
4. Snider GL, Lucey EC, Stone PJ. Pitfalls in antiprotease therapy of emphysema. Am J Respir Crit Care Med 1994;150:S131.
5. Tetley TD. Macrophages and the pathogenesis of COPD. Chest 2002; 121:156S-159S.
6. Shapiro SD. The macrophage in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1999;160:S29-S32.
7. Hautamaki RD, Kobayashi DM, Senior RM, Shapiro SD. Requirement for macrophage elastase for cigarette smoke-induced emphysema in mice. Science 1997;277:2002-2004.
8. 1-antitrypsin. Am J Respir Cell Mol Biol 2000;22:244-252.
9. Churg A, Zay K, Shay S, Xie C, Shapiro SD, Hendricks R, Wright JL. Acute cigarette smoke-induced connective tissue breakdown requires both neutrophils and macrophage metalloelastase in mice. Am J Respir Cell Mol Biol 2002;27:368-374.
10. Churg A, Dai J, Tai H, Xie C, Wright JL. Tumor necrosis factor-α is central to acute cigarette smoke-induced inflammation and connective tissue breakdown. Am J Respir Crit Care Med 2002;166:849-854.
11. Churg A, Wang RD, Tai H, Wang X, Xie C, Dai J, Shapiro SD, Wright JL. Macrophage metalloelastase mediates acute cigarette smoke-induced inflammation via tumor necrosis factor-α release. Am J Respir Crit Care Med 2003;167:1083-1089.
12. Barnes PJ, Karin M. Nuclear factor-κB: a pivotal transcription factor in chronic inflammatory disease. N Engl J Med 1997;336:1066-1071.
13. Kasahara Y, Tuder RM, Taraseviciene-Stewart L, Le Cras TD, Abman S, Hirth PK, Waltenberger J, Voelkel NF. Inhibition of VEGF receptors causes lung cell apoptosis and emphysema. J Clin Invest 2000;106:1311-1319.
14. Stone PJ, Morris SM, Griffin S, Mithieux S, Weiss AS. Building elastin: incorporation of recombinant human tropoelastin into extracellular matrices using nonelastogenic Rat-1 fibroblasts as a source for lysyl oxidase. Am J Respir Cell Mol Biol 2001;24:733-739.
15. + cells. Am J Respir Crit Care Med 2001;164:2220-2228.
16. 1-antitrypsin augmentation therapy. Am J Respir Crit Care Med 1999;160:1468-1472.